AI CAPITAL INTELLIGENCE
百奥几何 · Series A+ · Amount not standardized (see sources) · 2026-10-28
Financing facts, at a glance
百奥几何: financing disclosed on 2026-10-28, Series A+, Amount not standardized (see sources). Named investors: 国寿资本, 上海生物医药基金, 国开科创, 瑞力投资, 国方创投, 达晨财智. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.
百奥几何 is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Series A+, with an amount of Amount not standardized (see sources). Named investors include 国寿资本, 上海生物医药基金, 国开科创, 瑞力投资, 国方创投, 达晨财智.
- Disclosed company name
- 北京百奥几何生物科技有限公司
- Disclosure date
- 2026-10-28
- Round
- Series A+
- Financing amount
- Amount not standardized (see sources)
- Market coverage
- China
- Sector
- Industry AI / Drug discovery & life sciences
- Product form
- Models & APIs
Disclosed investors
国寿资本, 上海生物医药基金, 国开科创, 瑞力投资, 国方创投, 达晨财智
Sources for this round
- 百奥几何完成1亿美元A轮系列融资，带队迈向生命科学超级智能
news.pedaily.cn · Original publication date not recorded
Historical and background sources
- 达晨财智主投领域与最新投资情况_摩熵医药
pharnexcloud.com · Original publication date not recorded
Collection batch . Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.
Citation and coverage
Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market.
Wavesight AI｜百奥几何 · Series A+ · Amount not standardized (see sources) · 2026-10-28。百奥几何: financing disclosed on 2026-10-28, Series A+, Amount not standardized (see sources). Named investors: 国寿资本, 上海生物医药基金, 国开科创, 瑞力投资, 国方创投, 达晨财智. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment. Compiled and linked by Wavesight AI. Financing facts are attributable to the original disclosure sources; coverage is our recorded sample, not the whole market. https://www.zkdlj.vip/en/funding/FI-2cbb173107521cbd/#conclusion-overview
Link to conclusion